The cell stemness that is associated with TCF1 expression may be used for developing a novel approach to resolve CD8+ T cell resistance to ICB therapy in cancer patients and potentially fine-tune our current understanding of T cell exhaustion and differentiation. This evidence concerns the gene TCF7 and cancer.